These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 389103)

  • 1. The usefulness of theophylline in nonasthmatic airway obstruction.
    Schmidt R; Altschuler S
    Angiology; 1979 Nov; 30(11):744-9. PubMed ID: 389103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease.
    Murciano D; Auclair MH; Pariente R; Aubier M
    N Engl J Med; 1989 Jun; 320(23):1521-5. PubMed ID: 2498658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoproterenol challenge during placebo and oral theophylline therapy in chronic obstructive pulmonary disease.
    Dull WL; Alexander MR; Kasik JE
    Am Rev Respir Dis; 1981 Mar; 123(3):340-2. PubMed ID: 7224346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of theophylline in chronic obstructive lung disease.
    Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease.
    Mulloy E; McNicholas WT
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1030-6. PubMed ID: 8214921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic obstructive pulmonary disease with orally administered theophylline. A double-blind, controlled study.
    Alexander MR; Dull WL; Kasik JE
    JAMA; 1980 Nov; 244(20):2286-90. PubMed ID: 7001056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline and diaphragmatic contractility. Investigation of a dose-response relationship.
    Foxworth JW; Reisz GR; Knudson SM; Cuddy PG; Pyszczynski DR; Emory CE
    Am Rev Respir Dis; 1988 Dec; 138(6):1532-4. PubMed ID: 3059899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of theophylline and ipratropium on cognition in elderly patients with chronic obstructive pulmonary disease.
    Ramsdell JW; Henderson S; Renvall MJ; Salmon DP; Ferguson P
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):335-40. PubMed ID: 8612115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchodilator effect and serum theophylline level after combined treatment with fenoterol and theophylline in reversible chronic airflow obstruction.
    Lucena MI; Almagro J; Rius F; Sanchez de la Cuesta F
    Eur J Clin Pharmacol; 1988; 35(6):669-71. PubMed ID: 3234474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases.
    Lamont H; van der Straeten M; Pauwels R; Moerman E; Bogaert M
    Eur J Respir Dis; 1982 Jan; 63(1):13-22. PubMed ID: 7040097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic obstructive pulmonary disease with two sustained-release theophylline preparations.
    Giosue S; Bernocchi D; Parola D; Munno R; Mancini P
    J Int Med Res; 1987; 15(6):352-60. PubMed ID: 3325318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronopharmacodynamics and kinetics after symmetric and asymmetric multiple theophylline doses in patients with chronic obstructive pulmonary disease.
    Gimeno F; van Veenen R; Berg WC; Steenhuis EJ; Jonkman JH; Weibel MA
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):7-12. PubMed ID: 2744908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease.
    Mahler DA; Matthay RA; Snyder PE; Wells CK; Loke J
    Am Rev Respir Dis; 1985 Jan; 131(1):22-5. PubMed ID: 3966709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral aminophylline and dikydroxypropyl theophylline in reversible obstructive airway disease: a single-dose, double-blind, crossover comparison.
    Hudson LD; Tyler ML; Petty TL
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):367-72. PubMed ID: 4198297
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction.
    Taylor DR; Buick B; Kinney C; Lowry RC; McDevitt DG
    Am Rev Respir Dis; 1985 May; 131(5):747-51. PubMed ID: 4003919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term therapy with sustained-release theophylline.
    Myhre KI; Arnulf V; Walstad RA
    Pharmatherapeutica; 1985; 4(2):92-7. PubMed ID: 3903782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of combined oral theophylline and inhaled beta-adrenoceptor agonist bronchodilator therapy.
    Marlin GE; Hartnett BJ; Berend N; Hacket NB
    Br J Clin Pharmacol; 1978 Jan; 5(1):45-50. PubMed ID: 23134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiopulmonary effects of terbutaline and a bronchodilator combination in chronic obstructive pulmonary disease.
    Pierson DJ; Hudson LD; Stark K; Hedgecock M
    Chest; 1980 Feb; 77(2):176-82. PubMed ID: 6986238
    [No Abstract]   [Full Text] [Related]  

  • 19. Value of theophylline treatment in patients handicapped by chronic obstructive lung disease.
    McKay SE; Howie CA; Thomson AH; Whiting B; Addis GJ
    Thorax; 1993 Mar; 48(3):227-32. PubMed ID: 8497820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
    Goldstein MF; Chervinsky P
    Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.